Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Cited by (1,007)

Items 101–200 of 1,007

1. Current therapies and new developments in NASH
   Jean‐François Dufour, Quentin Mark Anstee, Elisabetta Bugianesi, Stephen A. Harrison, Rohit Seth Loomba, Valérie Paradis, Herbert Tilg, Vincent Wai‐Sun Wong, Shira Zelber‐Sagi · 2022 · Gut
2. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
   Farah Abdelhameed, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Kamaljit Kaur Chatha, Surinderjeet S. Chaggar, Μaria Dalamaga, Eva N. Kassi, Ioannis Kyrou, Harpal Singh Randeva · 2024 · Current Obesity Reports
3. High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
   Stefano Ciardullo, Tommaso Monti, Gianluca Perseghin · 2020 · Diabetes Care
4. Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
   Newsome, Philip, Francque, Sven, Harrison, Stephen, Ratziu, Vlad, Van Gaal, Luc, Calanna, Salvatore, Hansen, Morten, Linder, Martin, Sanyal, Arun · 2019 · Alimentary Pharmacology & Therapeutics
5. Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
   Javier Ampuero, Raluca Pais, R. Aller, Rocío Gallego‐Durán, Javier Crespo, Carmelo García‐Monzón, Jérôme Boursier, Eduardo Vilar‐Gómez, Salvatore Petta, Ming‐Hua Zheng et al. · 2019 · Clinical Gastroenterology and Hepatology
6. Ability of noninvasive scoring systems to identify individuals in the population at risk for severe liver disease
   Hagström, Hannes, Talbäck, Mats, Andreasson, Anna, Walldius, Göran, Hammar, Niklas · 2020 · Gastroenterology
7. RDW to Platelet Ratio: A Novel Noninvasive Index for Predicting Hepatic Fibrosis and Cirrhosis in Chronic Hepatitis B
   Baode Chen, Bo Ye, Jian Zhang, Lixiong Ying, Yu Chen · 2013 · PLoS ONE
8. Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease
   Simon, Tracey G., Henson, Jacqueline, Osganian, Stephanie, Masia, Ricard, Chan, Andrew T., Chung, Raymond T., Corey, Kathleen E. · 2019 · Clinical Gastroenterology and Hepatology
9. Real‐world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment‐naive, genotype 1 hepatitis C‐infected patients
   Lisa I. Backus, Pamela S. Belperio, Troy A. Shahoumian, Timothy P. Loomis, Larry A. Mole · 2016 · Hepatology
10. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography
    Massimo Pinzani, Francesco Vizzutti, Umberto Arena, Fabio Marra · 2008 · Nature Clinical Practice Gastroenterology &#38 Hepatology
11. Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B
    Yao‐Chun Hsu, Terry Cheuk‐Fung Yip, Hsiu J. Ho, Vincent Wai‐Sun Wong, Yen‐Tsung Huang, Hashem B. El‐Serag, Teng‐Yu Lee, Ming‐Shiang Wu, Jaw‐Town Lin, Grace Lai‐Hung Wong et al. · 2018 · Journal of Hepatology
12. Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Chehrehgosha, Haleh, Sohrabi, Masoud Reza, Ismail-Beigi, Faramarz, Malek, Mojtaba, Reza Babaei, Mohammad, Zamani, Farhad, Ajdarkosh, Hossein, Khoonsari, Mahmood, Fallah, Afshin Eshghi, Khamseh, Mohammad E. · 2021 · Diabetes Therapy
13. Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease
    Younossi, Zobair M., Stepanova, Maria, Ong, Janus, Yilmaz, Yusuf, Duseja, Ajay, Eguchi, Yuichiro, El Kassas, Mohamed, Castellanos-Fernandez, Marlen, George, Jacob, Jacobson, Ira M. et al. · 2019 · Clinical Gastroenterology and Hepatology
14. Complex non‐invasive fibrosis models are more accurate than simple models in non‐alcoholic fatty liver disease
    Leon Anton Adams, Jacob George, Elisabetta Bugianesi, Enrico Rossi, W. Bastiaan de Boer, David van der Poorten, Helena L. Ching, Max Kishor Bulsara, Gary P. Jeffrey · 2011 · Journal of Gastroenterology and Hepatology
15. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C
    Konstantin Kazankov, Francisco Barrera M., Holger Jon Møller, Bo Martin Bibby, Hendrik Vilstrup, Jacob George, Henning Grønbæk · 2014 · Hepatology
16. A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity
    Giovanni Guaraldi, Thomas D. Brothers, Stefano Zona, Chiara Stentarelli, Federica Carli, Andrea Malagoli, Antonella Santoro, Marianna Menozzi, Chiara Mussi, Cristina Mussini et al. · 2015 · AIDS
17. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis
    Laurent Castéra · 2009 · Journal of Viral Hepatitis
18. MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
    Tsubasa Tsutsumi, Mohammed Eslam, Takumi Kawaguchi, Sakura Yamamura, Atsushi Kawaguchi, Dan Nakano, Masahiro Koseki, Shinobu Yoshinaga, Hirokazu Takahashi, Keizo Anzai et al. · 2021 · Hepatology Research
19. Liver Fibrosis: A Compilation on the Biomarkers Status and Their Significance During Disease Progression
    Krishna Sumanth Nallagangula, Shashidhar Kurpad Nagaraj, V Lakshmaiah, Muninarayana Chandrappa · 2017 · Future Science OA
20. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
    Yong‐ho Lee, Yongin Cho, Byung‐Wan Lee, Cheol‐Young Park, Dae Ho Lee, Bong Soo, Eun‐Jung Rhee · 2019 · Diabetes & Metabolism Journal
21. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation
    Catriona Crossan, Emmanuel A. Tsochatzis, Louise Longworth, Kurinchi Selvan Gurusamy, Brian Ritchie Davidson, Manuel Rodríguez‐Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou et al. · 2015 · Health Technology Assessment
22. Advanced fibrosis is associated with incident cardiovascular disease in patients with non‐alcoholic fatty liver disease
    Jacqueline B. Henson, Tracey G. Simon, Alyson J. Kaplan, Stephanie A. Osganian, Ricard Masia, Kathleen E. Corey · 2020 · Alimentary Pharmacology & Therapeutics
23. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
    Richard K. Sterling, Keyur Patel, Andrés Duarte‐Rojo, Sumeet K. Asrani, Mouaz Alsawas, Jonathan A. Dranoff, Maria Isabel Fiel, Mohammad Hassan Murad, Daniel H. Leung, Deborah Levine et al. · 2024 · Hepatology
24. Technical Failure of MR Elastography Examinations of the Liver: Experience from a Large Single-Center Study
    Mathilde Wagner, Idoia Corcuera‐Solano, Grace C. Lo, Steven J. Esses, Joseph H. Liao, Cecilia Besa, Nelson Chen, Ginu Abraham, Maggie Fung, James S. Babb et al. · 2017 · Radiology
25. Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Monica A. Tincopa, Rohit Seth Loomba · 2023 · The Lancet. Gastroenterology & hepatology
26. . Towards a combined prognostic index for survival in HIV infection: the role of non-HIV biomarkers.
    Justice, AC, McGinnis, KA, Skanderson, M, Chang, CC, Gibert, CL, Goetz, MB, Rimland, D, Rodriguez‐Barradas, MC, Oursler, KK, Brown, ST et al. · 2010 · HIV Medicine
27. Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis
    David Edward Kaplan, Marina Serper, Rajni L. Mehta, Rena K. Fox, Binu V. John, Ayse Aytaman, Michelle L. Baytarian, Kristel K. Hunt, Jeffrey H. Albrecht, Basile M. Njei et al. · 2019 · Gastroenterology
28. A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores
    De Vincentis, Antonio, Tavaglione, Federica, Jamialahmadi, Oveis, Picardi, Antonio, Antonelli Incalzi, Raffaele, Valenti, Luca, Romeo, Stefano, Vespasiani-Gentilucci, Umberto · 2022 · Clinical Gastroenterology and Hepatology
29. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
    Jérôme Boursier, Maéva Guillaume, Vincent Leroy, Marie Irlès, Marine Roux, Adrien Lannes, Juliette Foucher, Floraine Zuberbuhler, Cyrielle Delabaudière, Justine Barthelon et al. · 2019 · Journal of Hepatology
30. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study
    Jennifer Y. Cui, B. Ang, William M. Haufe, Carolyn Hernandez, Elizabeth C. Verna, Claude B. Sirlin, Rohit Seth Loomba · 2015 · Alimentary Pharmacology & Therapeutics
31. Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis Improves Outcome
    Richard Todd Stravitz, Douglas M. Heuman, Nisha Chand, Richard K. Sterling, Mitchell L. Shiffman, Velimir A. Luketic, Arun Jayant Sanyal, Adil Habib, Anastasios A. Mihas, HoChong Gilles et al. · 2008 · The American Journal of Medicine
32. Risk assessment with gut microbiome and metabolite markers in NAFLD development
    Leung, Howell, Long, Xiaoxue, Ni, Yueqiong, Qian, Lingling, Nychas, Emmanouil, Siliceo, Sara Leal, Pohl, Dennis, Hanhineva, Kati, Liu, Yan, Xu, Aimin et al. · 2022 · Science Translational Medicine
33. Natural history of nonalcoholic fatty liver disease: A prospective follow‐up study with serial biopsies
    Patrik Nasr, Simone Ignatova, Stergios Kechagias, Mattias Ekstedt · 2017 · Hepatology Communications
34. Kingʼs Score: an accurate marker of cirrhosis in chronic hepatitis C
    Timothy Cross, Paolo M. Rizzi, Philip Berry, Matthew Bruce, B Portmann, Phillip Harrison · 2009 · European Journal of Gastroenterology & Hepatology
35. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
    Ditlev Nytoft Rasmussen, Maja Sofie Thiele, Stine Johansen, Maria Kjærgaard, Katrine Prier Lindvig, Mads Egerod Israelsen, Steen Antonsen, Sönke Detlefsen, Aleksander Ahm Krag, Ema Anastasiadou et al. · 2021 · Journal of Hepatology
36. Intestinal Virome in Patients With Alcoholic Hepatitis
    Lu Jiang, Sonja Lang, Yi Duan, Xinlian Zhang, Bei Gao, Jessica Chopyk, Leila K. Schwanemann, Meritxell Ventura Cots, Ramon A. Bataller, Francisco Bosques‐Padilla et al. · 2020 · Hepatology
37. Image analysis of liver collagen using sirius red is more accurate and correlates better with serum fibrosis markers than trichrome
    Yi Huang, W. Bastiaan de Boer, Leon Anton Adams, Gerry C. MacQuillan, Enrico Rossi, Paul J. Rigby, Spiro Raftopoulos, Max Kishor Bulsara, Gary P. Jeffrey · 2013 · Liver International
38. Comparison of Machine Learning Approaches for Prediction of Advanced Liver Fibrosis in Chronic Hepatitis C Patients
    Somaya Hashem, Gamal Esmat, Wafaa Elakel, Shahira M. Habashy, Safaa Abdel Raouf, Mahmoud ElHefnawi, Mohamed I. Eladawy, Mahmoud ElHefnawi · 2017 · IEEE Transactions on Computational Biology and Bioinformatics
39. Non-invasive assessment of liver fibrosis.
    Vasilios Papastergiou, Emmanuel A. Tsochatzis, Andrew Kenneth Burroughs · 2012 · Europe PMC (PubMed Central)
40. Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophages
    Tian, Siyuan, Zhou, Xia, Zhang, Miao, Cui, Lina, Li, Bo, Liu, Yansheng, Su, Rui, Sun, Keshuai, Hu, Yinan, Yang, Fangfang et al. · 2022 · Stem Cell Research & Therapy
41. Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection
    David Nunes, Catherine Fleming, Gwynneth D. Offner, Donald Edward Craven, Oren K. Fix, Timothy Heeren, Margaret James Koziel, Camilla S. Graham, Sheila Tumilty, Paul R. Skolnik et al. · 2010 · The American Journal of Gastroenterology
42. Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
    Juan Pablo Arab, Melisa Dirchwolf, Mário Reis Álvares‐da‐Silva, Francisco Barrera M., Carlos Benítez, Marlén Castellanos, Graciela Castro‐Narro, Norberto Carlos Chávez-Tapia, Daniela Chiodi, Helma Pinchemel Cotrim et al. · 2020 · Annals of Hepatology
43. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity
    Lisette Krassenburg, Raoel Maan, Alnoor S. Ramji, Michael Peter Manns, Markus Cornberg, Heiner H. Wedemeyer, Robert Jacobus de Knegt, Bettina E. Hansen, Harry L.A. Janssen, Robert Auke de Man et al. · 2020 · Journal of Hepatology
44. Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version
    Leonid Borisovich Lazebnik, Е. В. Голованова, Светлана Владимировна Туркина, K. L. Raikhelson, S. V. Okovityy, Oksana M. Drapkina, Igor Veniaminovich Maev, Martynov Ai, Г. Е. Ройтберг, Olga V. Khlynova et al. · 2021 · Экспериментальная и клиническая гастроэнтерология
45. Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk
    Ehimen C. Aneni, Ebenezer Oni, Seth Shay Martin, Michael Joseph Blaha, Arthur S. Agatston, Theodore Feldman, Emir Veledar, Raquel Conceição, José A.M. Carvalho, Raul Dias Santos et al. · 2015 · Journal of Hypertension
46. Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
    Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Masato Yoneda, Hideki Fujii, Yoshio Sumida, Hideyuki Hyogo, Yoshito Itoh, Masafumi Ono, Yuichiro Eguchi, Yasuaki Suzuki, Noriaki Aoki et al. · 2011 · Journal of Gastroenterology
47. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease
    Nobuyuki Toshikuni · 2014 · World Journal of Gastroenterology
48. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy
    Bogdan Procopeț, Annalisa Berzigotti · 2017 · Gastroenterology report
49. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants
    Veeral H. Ajmera, Beom Kyung Kim, Kun Yi Yang, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idılman, Mesut Gümüşsoy et al. · 2022 · Gastroenterology
50. Noninvasive Serum Fibrosis Markers for Screening and Staging Chronic Hepatitis C Virus Patients in a Large US Cohort
    Scott D. Holmberg, Mei Lü, Loralee B. Rupp, Lois E. Lamerato, Anne C. Moorman, Vinutha Vijayadeva, Joseph A. Boscarino, Emily M. Henkle, Stuart C. Gordon, for the Chronic Hepatitis Cohort Study (CHeCS) Investigators et al. · 2013 · Clinical Infectious Diseases
51. Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis
    Jaclyn R. Stonebraker, Chee Yee Ooi, Rhonda G. Pace, Harriet Corvol, Michael R. Knowles, Peter R. Durie, Simon C. Ling · 2016 · Clinical Gastroenterology and Hepatology
52. Systematic review: non‐invasive methods of fibrosis analysis in chronic hepatitis C
    Jenny O. Smith, Richard K. Sterling · 2009 · Alimentary Pharmacology & Therapeutics
53. Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States
    Ilya Golovaty, Phyllis C. Tien, Jennifer C. Price, Lila A. Sheira, Hilary Kessler Seligman, Sheri D. Weiser · 2019 · Journal of Nutrition
54. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease
    Qingling Chen, Pingping Hu, Xiaoxue Hou, Ye Sun, Mengfan Jiao, linya Peng, Zixing Dai, Xizhi Yin, Rui Liu, Yuwen Li et al. · 2024 · Cardiovascular Diabetology
55. Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
    Hannah K. Drescher, Sabine Weiskirchen, Ralf Weiskirchen · 2019 · Cells
56. Long‐Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver‐Related Outcomes
    Habiba Kamal, Gabriel Westman, Karolin Falconer, Ann‐Sofi Duberg, Ola Weiland, Susanna Haverinen, Rune Wejstål, Tony Carlsson, Christian Kampmann, Simon B. Larsson et al. · 2020 · Hepatology
57. Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection
    Masahiro Kobayashi, Fumitaka Suzuki, Shunichiro Fujiyama, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase et al. · 2016 · Journal of Medical Virology
58. Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
    Arun Jayant Sanyal, Sudha S. Shankar, Katherine P. Yates, James A. Bolognese, Erika Daly, Clayton A. Dehn, Brent A. Neuschwander‐Tetri, Kris V. Kowdley, Raj Vuppalanchi, Cynthia A. Behling et al. · 2023 · Nature Medicine
59. Accuracy of noninvasive scoring systems in assessing risk of death and liver-related endpoints in patients with nonalcoholic fatty liver disease
    Hagström, Hannes, Nasr, Patrik, Ekstedt, Mattias, Stål, Per, Hultcrantz, Rolf, Kechagias, Stergios · 2019 · Clinical Gastroenterology and Hepatology
60. Severity of non‐alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle
    Yoichiro Kitajima, Hideyuki Hyogo, Yoshio Sumida, Yuichiro Eguchi, Naofumi Ono, Takuya Kuwashiro, Kenichi Tanaka, Kazuhiro Takahashi, Toshihiko Mizuta, Iwata Ozaki et al. · 2013 · Journal of Gastroenterology and Hepatology
61. Risk Factors for Fatty Liver in the Multicenter AIDS Cohort Study
    Jennifer C. Price, Eric C. Seaberg, Rachel Latanich, Matthew Jay Budoff, Lawrence Kingsley, Frank Joseph Palella, Mallory D. Witt, Wendy S. Post, Chloe L. Thio · 2014 · The American Journal of Gastroenterology
62. Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1–Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy
    Caryn Gee Morse, Mary E. McLaughlin, Lindsay Matthews, Michael A. Proschan, Francine Thomas, Ahmed M. Gharib, Mones S. Abu-Asab, Abigail Orenstein, Ronald E. Engle, Xiaojun Hu et al. · 2015 · Clinical Infectious Diseases
63. Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study
    Samer Gawrieh, Lara Dakhoul, Ethan Miller, Andrew E. Scanga, Andrew S. deLemos, Carla D. Kettler, Heather N. Burney, Hao Liu, Hamzah Abu‐Sbeih, Naga Chalasani et al. · 2019 · Alimentary Pharmacology & Therapeutics
64. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology†
    Laurent Bellest, Valérie Eschwège, Raoul Y. Poupon, Olivier Chazouillères, Annie Robert · 2007 · Hepatology
65. Clinical, biochemical and histological differences between HIV ‐associated NAFLD and primary NAFLD : a case–control study
    Irine Vodkin, Mark A. Valasek, Ricki Bettencourt, Edward R. Cachay, Rohit Seth Loomba · 2014 · Alimentary Pharmacology & Therapeutics
66. Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt
    Heba Omar, Wafaa Elakel, Tamer Mahmoud Elbaz, Mohamed El‐Kassas, Kadry Elsaeed, Hewaida M Anwar El Shazly, Mohamed Said, Monkez Yousif, Ahmed Gomaa, Ahmed Medhat Nasr et al. · 2017 · Alimentary Pharmacology & Therapeutics
67. The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study
    for the Japan Study Group of Non-Alcoholic Fatty Liver Disease (JSG-NAFLD), Hiroshi Ishiba, Yoshio Sumida, Saiyu Tanaka, Masato Yoneda, Hideyuki Hyogo, Masafumi Ono, Hideki Fujii, Yuichiro Eguchi, Yasuaki Suzuki et al. · 2018 · Journal of Gastroenterology
68. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran
    Behnaz Amernia, Seyed Hamid Moosavy, Fatemeh Banookh, Ghazal Zoghi · 2021 · BMC Gastroenterology
69. Radiomics Analysis of Gadoxetic Acid–enhanced MRI for Staging Liver Fibrosis
    Hyo Jung Park, Seung Soo Lee, Bumwoo Park, Jessica Yun, Yu Sub Sung, Woo Hyun Shim, Yong Moon Shin, So Yeon Kim, So Jung Lee, Moon-Gyu Lee · 2018 · Radiology
70. Liver cirrhosis in HIV‐infected patients: prevalence, aetiology and clinical outcome
    Carol Castellares, Pablo Barreiro, Luz Martín‐Carbonero, Pablo Labarga, Eugenia Vispo, R. Casado, L. Galindo, Pilar García‐Gascó, Javier García‐Samaniego, Vincent Soriano · 2007 · Journal of Viral Hepatitis
71. Evolution of Noninvasive Tests of Liver Fibrosis Is Associated With Prognosis in Patients With Chronic Hepatitis C
    Julien Vergniol, Jérôme Boursier, Clélia Coutzac, Sandrine Bertrais, Juliette Foucher, Camille Angel, Faïza Chermak, Isabelle Fouchard Hubert, Wassil Merrouche, Frédéric Oberti et al. · 2014 · Hepatology
72. Exploring the landscape of steatotic liver disease in the general US population
    Stefano Ciardullo, Marco Carbone, Pietro Invernizzi, Gianluca Perseghin · 2023 · Liver International
73. Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort study
    Quentin Mark Anstee, Tina Landsvig Berentzen, Louise Maymann Nitze, Maximilian Jara, Anders B. Jensen, Mette Skalshøi Kjær, Kamal Kant Mangla, Jens M. Tarp, Kamlesh Khunti · 2023 · The Lancet Regional Health - Europe
74. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C
    Philippe Halfon, Yannick Bacq, Anne De Muret, Guillaume Pénaranda, Marc Bourlière, Denis Ouzan, Albert Tran, Danielle Botta, Christophe Renou, M.C. Bréchot et al. · 2006 · Journal of Hepatology
75. Serum wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis
    Umemura, Takeji, Joshita, Satoru, Sekiguchi, Tomohiro, Usami, Yoko, Shibata, Soichiro, Kimura, Takefumi, Komatsu, Michiharu, Matsumoto, Akihiro, Ota, Masao, Tanaka, Eiji · 2015 · American Journal of Gastroenterology
76. Serum Immunoglobulin Levels Predict Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
    McPherson, Stuart, Henderson, Elsbeth, Burt, Alastair D., Day, Christopher P., Anstee, Quentin M. · 2014 · Journal of Hepatology
77. Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors
    Edana Cassol, Vikas Misra, Alexander G. Holman, Anupa Kamat, Susan Morgello, Dana H. Gabuzda · 2013 · BMC Infectious Diseases
78. Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers
    Uchenna A. Agbim, Sumeet K. Asrani · 2019 · Expert Review of Gastroenterology & Hepatology
79. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
    Corpechot, Christophe, Carrat, Fabrice, Gaouar, Farid, Chau, Frederic, Hirschfield, Gideon, Gulamhusein, Aliya, Montano-Loza, Aldo J., Lytvyak, Ellina, Schramm, Christoph, Pares, Albert et al. · 2022 · Journal of Hepatology
80. Transfer learning radiomics based on multimodal ultrasound imaging for staging liver fibrosis
    Liyun Xue, Zhuoyun Jiang, Tiantian Fu, Qingmin Wang, Yuli Zhu, Meng Dai, Wenping Wang, Jinhua Yu, Hong Ding · 2020 · European Radiology
81. Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality
    Mara Sophie Vell, Rohit Seth Loomba, Arunkumar Krishnan, Kirk J. Wangensteen, Jonel Trebicka, Kate Townsend Creasy, Christian Trautwein, Eleonora Scorletti, Katharina Sophie Seeling, Leonida Hehl et al. · 2023 · JAMA Network Open
82. Coronary Aging in HIV‐Infected Patients
    Giovanni Guaraldi, Stefano Zona, Nikolaos A. Alexopoulos, Gabriella Orlando, Federica Carli, Guido Ligabue, Federica Fiocchi, Antonella Lattanzi, Rosario Rossi, Maria Grazia Modena et al. · 2009 · Clinical Infectious Diseases
83. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN
    Simon Lal, Loris Pironi, Geert Wanten, Jann Arends, Federico Bozzetti, Cristina Cuerda, Francisca Joly, Darlene Kelly, Michael Staun, Kinga Szczepanek et al. · 2018 · Clinical Nutrition
84. The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C
    Jeffrey S. McCombs, Tara Matsuda, Ivy Q. Tonnu-Mihara, Sammy Saab, P. Hines, Gilbert L’Italien, Timothy Juday, Yong Yuan · 2013 · JAMA Internal Medicine
85. High liver fibrosis index FIB‐4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers
    Beomseok Suh, Sehhoon Park, Dong Wook Shin, Jae Moon Yun, Hyung‐Kook Yang, Su Jong Yu, Cheong‐Il Shin, Jin‐Soo Kim, Eunmi Ahn, Hyejin Lee et al. · 2014 · Hepatology
86. Poor Awareness of Liver Disease Among Adults With NAFLD in the United States
    Saleh A. Alqahtani, James M. Paik, Rakesh Biswas, Tamoore Arshad, Linda L Henry, Zobair M. Younossi · 2021 · Hepatology Communications
87. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension
    Moon Young Kim · 2014 · World Journal of Gastroenterology
88. Changes of non‐invasive markers and FibroScan values during HCV treatment
    J. Vergniol, Juliette Foucher, Laurent Castéra, Pierre–Henri Bernard, R. Tournan, Éric Terrebonne, Elise Chanteloup, Wassil Merrouche, Patrice Couzigou, Victor de Lédinghen · 2009 · Journal of Viral Hepatitis
89. The association of histologic and noninvasive tests with adverse clinical and patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis
    Younossi, Zobair M., Anstee, Quentin M., Wai-Sun Wong, Vincent, Trauner, Michael, Lawitz, Eric J., Harrison, Stephen A., Camargo, Marianne, Kersey, Kathryn, Subramanian, G. Mani, Myers, Robert P. et al. · 2021 · Gastroenterology
90. Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection
    Pathik M. Parikh, John Denis Ryan, Emmanuel A. Tsochatzis · 2017 · Annals of Translational Medicine
91. Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis
    Federica Tavaglione, Oveis Jamialahmadi, Antonio De Vincentis, Sami U. Qadri, Mohammad Erfan Mowlaei, Rosellina Margherita Mancina, Ester Ciociola, Simone Carotti, Giuseppe Perrone, Vincenzo Bruni et al. · 2022 · Clinical Gastroenterology and Hepatology
92. The steatosis‐associated fibrosis estimator (SAFE) score: A tool to detect low‐risk NAFLD in primary care
    Pimsiri Sripongpun, W. Ray Kim, Ajitha Mannalithara, Vivek Charu, Anna A. Vidovszky, Steven M. Asch, Manisha Desai, Sun H. Kim, Allison J. Kwong · 2022 · Hepatology
93. Liver Stiffness Measurements in Patients with Different Stages of Nonalcoholic Fatty Liver Disease: Diagnostic Performance and Clinicopathological Correlation
    Ramesh K. Kumar, Archana Rastogi, Manoj Kumar Sharma, Vikram Bhatia, Pankaj Kumar Tyagi, Praveen Sharma, Hitendra Garg, K. Kumar, Chhagan Bihari, Shiv Kumar Sarin · 2012 · Digestive Diseases and Sciences
94. The combination of a blood test and Fibroscan improves the non‐invasive diagnosis of liver fibrosis
    Jérôme Boursier, Julien Vergniol, Apollinaire Sawadogo, Taoufiq Dakka, Sophie Michalak, Yves Gallois, Véronique Le Tallec, Frédéric Oberti, Isabelle Fouchard‐Hubert, Nina Dib et al. · 2009 · Liver International
95. Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease
    Cholankeril, George, Kramer, Jennifer R., Chu, Jinna, Yu, Xian, Balakrishnan, Maya, Li, Liang, El-Serag, Hashem B., Kanwal, Fasiha · 2023 · Journal of Hepatology
96. Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease
    Sarah Shili‐Masmoudi, Grace Lai‐Hung Wong, Jean‐Baptiste Hiriart, Ken Liu, Faïza Chermak, Sally She‐Ting Shu, Juliette Foucher, Yee‐Kit Tse, Pierre–Henri Bernard, Terry Cheuk‐Fung Yip et al. · 2019 · Liver International
97. Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD
    Tolga Gidener, Omar T. Ahmed, Joseph J. Larson, Kristin C. Mara, Terry M. Therneau, Sudhakar Kundapur Venkatesh, Richard L. Ehman, Meng Yin, Alina M. Allen · 2020 · Clinical Gastroenterology and Hepatology
98. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers
    Matilde Sánchez‐Conde, María Luisa Montes-Ramírez, Pilar Miralles, J. M. Castro Alvarez, José María Bellón, Margarita Ramírez, José Ramón Arribas, Isabel Gutiérrez, J. C. López, Jaime Cosín et al. · 2009 · Journal of Viral Hepatitis
99. Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients
    L. Denkmayr, Alexandra Feldman, Lars Stechemesser, Sebastian K. Eder, Stephan Zandanell, Michael Schranz, Michael Straßer, Ursula Huber-Schönauer, Stephan Buch, Jochen Hampe et al. · 2018 · Journal of Clinical Medicine
100. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
     Dong Hyun Sinn, Soo Jin Cho, Seonhye Gu, Donghyeong Seong, Danbee Kang, Hyun‐Kyoung Kim, Byoung-Kee Yi, Seung Woon Paik, Eliseo Güallar, Juhee Cho et al. · 2016 · Gastroenterology